KALA BIO, Inc. (KALA)
NASDAQ: KALA · Real-Time Price · USD
0.2427
-0.0098 (-3.88%)
Mar 19, 2026, 10:25 AM EDT - Market open
KALA BIO Employees
KALA BIO had 38 employees as of December 31, 2024. The number of employees decreased by 5 or -11.63% compared to the previous year.
Employees
38
Change (1Y)
-5
Growth (1Y)
-11.63%
Revenue / Employee
n/a
Profits / Employee
-$943,184
Market Cap
1.99M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 38 | -5 | -11.63% |
| Dec 31, 2023 | 43 | 9 | 26.47% |
| Dec 31, 2022 | 34 | -158 | -82.29% |
| Dec 31, 2021 | 192 | 4 | 2.13% |
| Dec 31, 2020 | 188 | 52 | 38.24% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Jaguar Health | 49 |
| Scinai Immunotherapeutics | 31 |
| Lyra Therapeutics | 30 |
| Calidi Biotherapeutics | 28 |
| Azitra | 12 |
| BioRestorative Therapies | 11 |
| Onconetix | 5 |
| 60 Degrees Pharmaceuticals | 3 |
KALA News
- 1 day ago - Red Light Holland Engages Kala Bio's Researgency.AI Platform to Support Clinical Development of Filament's Patented PEX010 Botanical Psilocybin Drug Candidate - GlobeNewsWire
- 1 day ago - Red Light Holland Engages Kala Bio's Researgency.ai Platform to Support Clinical Development of Filament Health's Patented PEX010 Botanical Psilocybin Drug Candidate - Newsfile Corp
- 7 days ago - Younet.ai Highlights Researgency.ai Collaboration with Kala Bio (KALA) as New "AutoResearch" Milestone Signals the Rise of Autonomous Research Agents - Newsfile Corp
- 8 days ago - Kala Bio Launches a Revolution for Biotech- First AI Agent Deploying in 14 Days as $180 Billion Agentic AI Healthcare Revolution Accelerates - GlobeNewsWire
- 10 days ago - Stock Trend Capital Provides Younet AI Investment Update - Newsfile Corp
- 15 days ago - KALA BIO Announces Strategic Initiative to Deploy and Continue to Develop an On-Premises AI Infrastructure Platform for the Biotech Industry; Enters Into Platform Development and Exclusive License Agreement for Proprietary AI Research Platform “Researgency” - GlobeNewsWire
- 2 months ago - KALA BIO Settles Approximately $10.6 million of Debt - GlobeNewsWire
- 3 months ago - KALA BIO Announces $10 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules - GlobeNewsWire